###### Strengths and limitations of this study

-   With our study, we generated relevant and new outcome data on critically ill patients who underwent interhospital transportation by comparing the Sequential Organ Failure Assessment (SOFA) score on the day of transport with the 24 h post-transport SOFA score.

-   We briefly analyse all cases of 24 h post-transport mortality.

-   This study is a descriptive analysis of a single-centre database with a limited number of patients and with only one post-transport data set (SOFA score) 24 h after mobile intensive care unit transport.

-   Owing to the single-centre characteristic of the study, selection bias cannot be ruled out.

Introduction {#s1}
============

Transport of critically ill patients is known to be a high-risk procedure with a significant rate of adverse events; nearly 68% of serious adverse events have been documented in up to 89% of intrahospital transports.[@R1] The adequate provision of qualified and experienced staff along with specially designed and well-maintained equipment are found to be protective,[@R2] especially since during the interhospital transportation, the patients' safety can be compromised due to the absence of qualified medical staff and the lack of adequate resuscitation equipment.[@R6] In a report of the Dutch healthcare authority 'Inspectie voor de Gezondheidszorg' from 2005, the authors concluded that interhospital transports in the Netherlands were often performed with inadequately staffed and underutilised transport facilities.[@R11] Therefore, the Dutch government by law assigned seven tertiary hospitals to carry out interhospital transports of critically ill adult patients by a mobile intensive care unit (MICU) daily, from 07:00 until 23:00. Patients in need of an immediate life-saving intervention in an expertise centre were beyond the scope of MICU transportation.[@R12]

A MICU generally consists of a high-volume ambulance, a special trolley with all monitoring, resuscitation and treatment equipment fixed to it and a dedicated retrieval team, including an ambulance driver (from the local emergency medical service), an intensive care nurse and an intensive care physician (both from the local tertiary intensive care unit (ICU)). All clinical team members are trained in the local simulation centre before performing the first transport and the first couple of transports are under direct supervision of an experienced colleague.

Debriefing takes place routinely; all critical events that occurred during transport have been discussed with the medical coordinator and have been registered nationally. Furthermore, there is a 1-day simulator-based follow-up training for all clinical MICU team members once a year.

The Sequential Organ Failure Assessment (SOFA) score is an established, good validated intensive care score which is used to describe worsening or improvement in the patient's condition and has a good correlation with mortality, with a higher score indicating worse outcome.[@R13] For all transports, the SOFA scores have been calculated at the day of transport and 24 h after transport. In this paper, changes in these two SOFA scores are used to describe short-term outcome. Moreover, regarding the patients who died within the first 24 h after transport, we performed further analysis to determine if there were transport-related effects on the 24 h post-transport mortality.

Objectives {#s2}
==========

To evaluate short-term (24 h after transport) outcome and mortality after interhospital transports of intensive care patients in the South East of the Netherlands.

Materials and methods {#s3}
=====================

All transports performed by the MICU Maastricht between March 2009 and December 2011 were prospectively documented. All relevant data were obtained from the patient charts and transferred into a dedicated database by a data manager of the ICU department. All interhospital transports concerned adult intensive care patients in the southeast region of the Netherlands. Forty-two items were scored, including patient demographics; diagnosis; SOFA score pretransportation and post-transportation; use of vasoactive medications; ventilator settings; transport-related factors such as transport time, transport team members; additional medical devices such as extracorporeal membrane oxygenation (ECMO) or intra-aortic balloon counter pulsation (IABP); and critical events. Critical events were registered following national definitions with technical (eg, ambulance, trolley, equipment-related) and non-technical events (eg, drop in oxygen saturation by more than 10% or drop in mean arterial pressure by more than 20 mm Hg for at least 10 min). The MICU nurse called the receiving ICU 24 h after the transport to obtain information about the patient\'s status (deceased or if alive actual SOFA score).Only transports with complete data sets, including a pretransport and a post-transport SOFA score, were analysed. All transports were performed and documented by a specialised retrieval team. In 24 from the 368 cases, the follow-up SOFA score was missing; so 344 data sets were included for analysis.

Numerical variables are presented by mean (SD) or median (range) if the data are clearly not normally distributed based on histograms. For categorical variables, frequency (%) is given. Differences in numerical variables between patients who died versus patients who did not die within 24 h after transport were analysed using independent samples t tests or Mann-Whitney U tests, wherever appropriate. χ^2^ or Fisher\'s exact test was used for categorical variables. All analyses were performed using the Statistical Package for the Social Sciences (V.20.0, SPSS Inc, Chicago, Illinois, USA).

A two-sided p value ≤0.05 was considered statistically significant.

Results {#s4}
=======

Patient characteristics {#s4a}
-----------------------

A total of 368 transports were performed from March 2009 until December 2011, from which 344 data sets were complete. A broad range of patients, in terms of severity of illness (mean SOFA score 8.8, range 0--20), were transported, including 15 patients on ECMO. Nearly all patients were mechanically ventilated and the majority of the patients were in need of a higher level ICU or for advanced treatment options, for example, heart transplantation or treatment in a burn unit. The median days of admission before transport was 4, reflecting the fact that urgent transports were not performed with the MICU system. Additional medical devices as ECMO, nitric oxide (NO) or IABP, indicating severe illness, were present in 6.4% of the transports.

In the subgroup of patients transported with veno-venous ECMO, all devices have been placed off centre by the transport team supported by a perfusionist from the local tertiary centre. The data of this subgroup are separately described in the [tables 1](#BMJOPEN2014006801TB1){ref-type="table"} and [2](#BMJOPEN2014006801TB2){ref-type="table"}.

###### 

Patient characteristics

  ------------------------------------------------------------ -----------------
  Number (%)                                                   344 (100)
  Age (SD)                                                     58 (16.4)
  Male sex (%)                                                 236 (68.6)
  SOFA score before transport (SD/range)                       8.8 (4.1/0--20)
  Need for higher level ICU or advanced therapy (%)            218 (63.4)
  Median days of hospital admission before transport (range)   4 (0--244)
  P/F ratio (SD)                                               246 (113)
  Use of continuous vasoactive medication (%)                  152 (44.2)
  pH at time of request for transport (SD)                     7.37 (0.1)
  Additional medical devices (%)                               22 (6.4)
  Invasive mechanical ventilation (%)                          311 (90.4)
  Non-invasive mechanical ventilation (%)                      6 (1.7)
  ------------------------------------------------------------ -----------------

                                                               V-V ECMO            V-A ECMO            All ECMO patients
  ------------------------------------------------------------ ------------------- ------------------- -------------------
  Number                                                       7                   8                   15
  Age (SD)                                                     40 (15.9)           52 (8.6)            46 (13.4)
  Male sex (%)                                                 5 (71.4)            7 (87.5)            12 (80.0)
  SOFA score before transport (SD/range)                       14.0 (1.5/13--17)   13.8 (2.4/11--17)   13.9 (2.0/11--17)
  Days of hospital admission before transport (median/range)   3 (0--27)           4 (2--10)           4 (0--27)
  P/F ratio (SD)                                               92 (41)             240 (87)            177 (106)
  Use of continuous vasoactive medication (%)                  6 (85.7)            6 (75.0)            12 (80.0)
  pH at time of request for transport (median/SD)              7.28 (0.1)          7.45 (0.1)          7.37 (0.12)

Vasoactive medication: norepinephrine, dobutamine, nitroglycerine.

Additional medical devices: V-V and V-A ECMO, IABP, NO.

Short-term cardiac assist devices: V-A ECMO or IABP.

ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon counter pulsation; NO, nitric oxide; P/F, PaO~2~/FiO~2~ ratio; SOFA, Sequential Organ Failure Assessment; V-A ECMO, veno-arterial ECMO; V-V ECMO, veno-venous ECMO.

###### 

Transport characteristics and outcomes

  ------------------------------------------------------------------------------------- ---------------------
  SOFA score before transport of all patients (SD/range)                                8.8 (4.1/0--20)
  SOFA score before transport of patients being alive 24 h after transport (SD/range)   8.6 (4.0/0--19)
  SOFA score after transport (SD/range)                                                 8.4 (4.5/0--24)
  Patients deceased within 24 h after transport (%)                                     14 (4.1)
  Patients not being transported (%)                                                    2 (0.6)
  Critical events (%)                                                                   22 (6.4)
  Total transport time in hours (SD/range)                                              5.6 (1.9/1.5--11.5)
  ------------------------------------------------------------------------------------- ---------------------

                                                      V-V ECMO               V-A ECMO              All ECMO patients
  --------------------------------------------------- ---------------------- --------------------- ---------------------
  SOFA score before transport (SD/range)              14.0 (1.5/13--17)      13.8 (2.4/11--17)     13.9 (2.0/11--17)
  SOFA score after transport (SD/range)               15.0 (4.2/12--24)      12.2 (2.1/10--16)     13.7 (3.6/10--24)
  Critical events (%)                                 0 (0)                  2 (25.0)              2 (13.3)
  Transport time in hours (SD/range)                  9.9 (1.4/8.5--10.75)   8.7 (2.7/5.5--11.5)   9.3 (2.2/5.5--11.5)
  Patients deceased within 24 h after transport (%)   0 (0)                  2 (25.0)              2 (13.3)

Total transport time: departure MICU team from our unit until return of the team plus time for updating the trolley.

Vasoactive medication: norepinephrine, dobutamine, nitroglycerine.

Additional medical devices: V-V and V-A ECMO, IABP, NO.

Short-term cardiac assist devices: V-A ECMO or IABP.

ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon counter pulsation; MICU, mobile intensive care unit; NO, nitric oxide; SOFA, Sequential Organ Failure Assessment; V-A ECMO, veno-arterial ECMO; V-V ECMO, veno-venous ECMO.

Transport characteristics and outcome parameters {#s4b}
------------------------------------------------

There is a non-significant decrease in SOFA score after transport (8.6 vs 8.4, p=0.174) for the group to be alive 24 h after transport (n=330). In total, there were 22 critical events reported with 2 severe events needing immediate interventions (spontaneous ventricular tachycardia, disconnection of hub from ECMO tubing system). The majority of events were technical problems, for example, with the power supply of the ambulance or one of the medical devices. None of the latter problems affected the patient\'s safety because the transport trolley has a stand-alone time from 2 h and back-up devices for ventilation, monitoring and resuscitation can be found in the ambulance.

The mean total transport time was 5.6 h, which can be explained by the decentred position of the Maastricht Medical Centre and the absence of heart/lung transplantation and burn units in our region. Furthermore, we found that the 15 ECMO transports exceeded the mean transport time by nearly 4 h ([table 2](#BMJOPEN2014006801TB2){ref-type="table"}).

Mortality {#s4c}
---------

In all, 14 patients died within 24 h after transport (4.1%).We compared the group of patients who died with the group of patients who were alive 24 h after transport. Those patients who died within 24 h after transportation had a significantly higher SOFA score before transport (12.3 vs 8.6, p\<0.001) indicating a higher severity of illness, were older, more often on vasoactive medication and more frequently had a cardiac diagnosis.

No differences were found in transport-related factors in terms of the number of critical events or total transport time ([table 3](#BMJOPEN2014006801TB3){ref-type="table"}).

###### 

Characteristics of patients alive and deceased within 24 h after transport

                                                               Patients alive 24 h after transport (n=330)   Patients deceased within 24 h after transport (n=14)   p Value
  ------------------------------------------------------------ --------------------------------------------- ------------------------------------------------------ ---------
  Age (SD)                                                     58 (16.6)                                     68 (7.5)                                               \<0.001
  Male sex (%)                                                 227 (68.5)                                    9 (64.3)                                               0.722
  SOFA score before transport (SD/range)                       8.6 (4/0--19)                                 12.3 (3.5/9--20)                                       \<0.001
  Need for higher level ICU or advanced therapy (%)            206 (62.4)                                    12 (85.7)                                              0.076
  Critical events (%)                                          21 (6.4)                                      1 (7.1)                                                0.611
  Total transport time in hours (SD/range)                     5.6 (1.9/1.5--11.5)                           5.5 (1.7/4--8.5)                                       0.850
  Median days of hospital admission before transport (range)   4 (0--244)                                    4 (0--19)                                              0.072\*
  P/F ratio (SD)                                               249 (113)                                     192 (96)                                               0.064
  Use of continuous vasoactive medication (%)                  142 (43.0)                                    10 (71.3)                                              0.036
  pH at time of request for transport (SD)                     7.38 (0.09)                                   7.23 (0.18)                                            0.011
  Cardiac diagnosis (%)                                        75 (22.7)                                     9 (64.3)                                               0.001
  Additional medical devices (%)                               19 (5.8)                                      3 (21.4)                                               0.052
  Short-term cardiac assist devices (%)                        11 (3.3)                                      3 (21.4)                                               0.015
  Invasive mechanical ventilation (%)                          298 (90.3)                                    13 (92.9)                                              \>0.999
  Non-invasive ventilation (%)                                 5 (1.5)                                       1 (7.1)                                                0.222
  Oxygen supply nasal or mask (%)                              27 (8.2)                                      0 (0)                                                  0.613

\*Mann-Whitney U test.

Total transport time: departure MICU team from our unit until return of the team plus time for updating the trolley.

Vasoactive medication: norepinephrine, dobutamine, nitroglycerine.

Cardiac diagnosis: CPR, severe valve dysfunction, cardiogenic shock, myocardial infarction.

Additional medical devices: V-V and V-A ECMO, IABP, NO.

Short-term cardiac assist devices: V-A ECMO or IABP.

CPR, cardiopulmonary resuscitation; ECMO, extracorporeal membrane oxygenation; IABP, intra-aortic balloon counter pulsation; ICU, intensive care unit; MICU, mobile intensive care unit; NO, nitric oxide; P/F, PaO~2~/FiO~2~ ratio; SOFA, Sequential Organ Failure Assessment; V-A ECMO, veno-arterial ECMO; V-V ECMO, veno-venous ECMO.

To get more insight on the individual cases of those patients who died, we reviewed the patients' charts. Two patients died after arrival of the transport team in the referral hospital before transportation could be initiated because of massive bleeding and after massive aspiration.

Two patients with postcardiotomy left ventricular failure, transported with veno-arterial ECMO (V-A ECMO) and IABP, died in the perioperative period of surgical implantation of a left ventricular assist device. More than one-third of the patients (5/14) died within 24 h because the medical team decided to retain further therapy; three patients died due to refractory cardiogenic shock and two patients went into a pulseless electric activity secondary to multiorgan failure ([table 4](#BMJOPEN2014006801TB4){ref-type="table"}).

###### 

Patient characteristics and cause of death of patients deceased within 24 h after transport

  n    Major diagnosis before transport                         SOFA score   Reason for transfer                                      Special remarks                                                                                               Cause of death
  ---- -------------------------------------------------------- ------------ -------------------------------------------------------- ------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  1    Cardiogenic shock, severe aortic valve stenosis          13           Further treatment in EC                                                                                                                                                Refractory cardiogenic shock, no surgical options
  2    Postcardiotomy left ventricular failure                  17           Further treatment in EC                                  Transport with V-A ECMO and IABP                                                                              Perioperative death (LVAD)
  3    Cardiac arrest caused by MI                              12           No ICU beds available at tertiary centre                                                                                                                               Withdrawal of therapy because of persistent cardiogenic shock and anoxic encephalopathy
  4    Hypovolemic shock caused by bleeding pancreatic tumour   11           Further treatment in EC                                                                                                                                                During transfer from patient bed to transport trolley a massive rebleeding occurred, after discussion with intensivist from local hospital transport was cancelled
  5    Cardiogenic shock after MI and CPR                       12           Further treatment in EC                                  IABP (placed by MICU team)                                                                                    Withdrawal of therapy because of MOF and poor preadmission performance
  6    Cardiogenic shock after MI with RF                       7            Further treatment in EC                                  Transport on NIV                                                                                              Refractory cardiogenic shock
  7    MOF/severe liver failure                                 20           Further treatment in EC                                                                                                                                                PEA due to MOF
  8    CPR due to VF                                            10           No ICU beds available at local hospital                                                                                                                                Withdrawal of therapy because of poor neurological prognosis and poor preadmission performance
  9    Severe mitral valve insufficiency                        14           Further treatment in EC                                                                                                                                                Refractory cardiogenic shock, no surgical options
  10   Postcardiotomy left ventricular failure                  15           Further treatment in EC                                  Transport with V-A ECMO and IABP                                                                              Perioperative death (LVAD)
  11   CPR due to hypoxaemia                                    8            No ICU beds available at local hospital                  10 min delay before BLS                                                                                       Withdrawal of therapy because of poor neurological status with brainstem dysfunction
  12   Traumatic brain injury                                   15           Further treatment in trauma centre                                                                                                                                     Withdrawal of therapy because of severe traumatic brain injury with brainstem dysfunction, no surgical options
  13   Respiratory failure after aspiration MRSA+               12           No isolation bed available at local ICU (MRSA patient)   6 h treatment at isolation box on general ward at local hospital with MICU equipment by MICU/local ICU team   Unless maximum therapy further deterioration occurred, patient died due to refractory hypoxaemia
  14   MOF due to legionella pneumonia                          17           Further treatment in EC                                                                                                                                                PEA due to MOF

BLS, basic life support; CPR, cardiopulmonary resuscitation; EC, expertise centre; IABP, intra-aortic balloon counter pulsation; ICU, intensive care unit; LVAD, left ventricular assist device; MI, myocardial infarction; MICU, mobile intensive care unit; MOF, multiorgan failure; MRSA, methicillin-resistant *Staphylococcus aureus*; NIV, non-invasive ventilation; PEA, pulse less electric activity; RF, respiratory failure; SOFA, Sequential Organ Failure Assessment; V-A ECMO, veno-arterial ECMO; VF, ventricular fibrillation.

Discussion {#s5}
==========

This study shows that interhospital transportation of critically ill patients with our MICU and a dedicated team can be performed without clinically relevant negative effects on the patient's condition and a critical event rate in line with current literature. The monitoring of severity of illness on the day of transport and 24 h after transport was introduced as a new parameter that can be used to detect transport-related effects on the patients' condition. The patients who died within 24 h after transportation had a higher severity of illness, were older, more often on vasoactive medication and most had a cardiac diagnosis.

Within the ongoing discussion concerning concentration of healthcare facilities, it is to be expected that qualified transport of critically ill patients will become a key factor of success in future intensive care medicine development.[@R14] In this context, it seems to be of utmost importance not only to have qualified interhospital transportation systems, but also to develop practical and efficient tools that help to decide which individual patient will benefit from transportation to another hospital without undergoing major transportation risk. In 5 of the 14 patients who died within 24 h after transport in our population, further aggressive treatment was withheld in the accepting ICU. Retrospectively, it is questionable whether all these patients should have been transported, which emphasises the need for valid pretransport triage criteria.

In 2012, Barratt *et al*[@R18] concluded, in a propensity-matched cohort analysis with more than 300 000 patients, that there was no statistical significant difference in hospital mortality for the 759 patients undergoing a non-clinical interhospital critical care transfer, but that a level of harm, that may be considered as clinically relevant, cannot be ruled out.

So, do we need specialised retrieval teams and what parameters should we use to determine the quality of a transport facility?

Belway *et al*[@R19] concluded in a systematic review in 2006, that current data are insufficient to determine whether the use of specialist transport personnel improves patient outcome. Moreover, also in 2006, Fan *et al*[@R20] concluded in a systematic review that insufficient data exist to draw firm conclusions regarding the mortality, morbidity or risk factors associated with the interfacility transport.

In general, proxy parameters, critical event rate, number of physiological parameters beyond a predefined threshold or short-term mortality, are used and studies using these parameters suggest that specialised retrieval teams perform better.[@R8] [@R9] [@R21] [@R22] In this study, short-term mortality and short-term morbidity was analysed by monitoring SOFA scores directly, before and 24 h after transport; this is a potentially practical parameter. Nevertheless, we agree with the conclusions of Fan *et al*, and doubt whether the aforementioned parameters sufficiently reflect quality of interhospital transport.

A lot of non-transport-related factors interfere with short-term morbidity and certainly with short-term mortality.[@R23] However, what does a decrease in oxygen saturation below a certain threshold mean if we do not see this in the context of the severity of the patient\'s lung failure?

The incidence of critical events during transportation of patients varies in the literature. It is important, however, to emphasise that there is no clear standard definition for adverse events during transportation. Fanara *et al*[@R1] described a critical event rate for intrahospital transport of up to 68%, with serious adverse events ranging between 4.2% and 8.9%. Wiegersma *et al*[@R9] report a critical event rate for interhospital transport of 12.5% due to technical problems, but without the need for immediate intervention. Uusaro *et al*[@R26] reported no major medical or technical complications during interhospital transport of severely hypoxic patients. An analysis of 191 mechanical-ventilated patients undergoing rotary wing transport showed that 22% of the patients experienced a minor event.[@R27] In our study, a critical event rate of 6.4% was found which appears in line with current literature.

The question rises as to whether the 4.1% 24 h mortality in the present study was influenced by transport-related factors. The pretransport data of these non-survivors as compared with the survivors showed higher SOFA scores, lower pH, higher age, the frequent use of vasoactive/inotropic medication, more cardiac diagnoses and more often transport with short-term cardiac assist devices. Since there were no differences between the two groups of patients in the number of critical events or other transport-related parameters, but a significant difference concerning severity of illness, we conclude that mainly the pre-existing clinical status was responsible for the difference in mortality between the two groups, and that the contribution of the transport per se was limited. Certainly, the low number of patients in the non-survivor group makes it difficult to draw meaningful conclusions. Moreover, knowledge on the physiological impact of transportation on critically ill patients is scarce and possible factors that may contribute are yet unknown.

There are several limitations to the present paper. This study is a descriptive analysis of a single-centre database with a limited number of patients and with only one post-transport data set (SOFA score) 24 h after MICU transport. Owing to the single-centre character of the study in a certain region of the Netherlands, selection bias cannot be ruled out. Moreover, transportation was carried out by a dedicated, well-trained retrieval team in a fully equipped ambulance which might not be available in many other centres or countries, and limits generalisability.

Although these data are not specific enough to answer the question of which patient will benefit from being transported and how to monitor quality of interhospital transport, our results do suggest that there are certain patient characteristics indicating a high risk for short-term mortality and that measuring short-term outcome appears useful to determine whether there is a negative transport-related effect on the patients' clinical condition.

Conclusion {#s6}
==========

Interhospital transport of intensive care patients performed by a specialised retrieval team with advanced ICU equipment in the South East of the Netherlands has no negative effect on short-term (24 h) outcomes. Short-term (24 h) mortality after MICU transport appears mainly influenced by the natural course of critical illness and decisions to retain further aggressive therapy in individual patients. More research is required, data on stratification of patients who will benefit from transportation and the development of a system that enables evaluation of the quality of transportation seem most urgent.
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